NO900025L - Pyrrolylfenyl-substituerte hydroksamsyrederivater. - Google Patents

Pyrrolylfenyl-substituerte hydroksamsyrederivater.

Info

Publication number
NO900025L
NO900025L NO90900025A NO900025A NO900025L NO 900025 L NO900025 L NO 900025L NO 90900025 A NO90900025 A NO 90900025A NO 900025 A NO900025 A NO 900025A NO 900025 L NO900025 L NO 900025L
Authority
NO
Norway
Prior art keywords
pyrrolylphenyl
acid derivatives
hydroxamic acid
substituted hydroxamic
substituted
Prior art date
Application number
NO90900025A
Other languages
English (en)
Norwegian (no)
Other versions
NO900025D0 (no
Inventor
Jan W F Wasley
Karl Olaf Gelotte
Harold Meckler
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO900025D0 publication Critical patent/NO900025D0/no
Publication of NO900025L publication Critical patent/NO900025L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO90900025A 1989-01-05 1990-01-04 Pyrrolylfenyl-substituerte hydroksamsyrederivater. NO900025L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29390889A 1989-01-05 1989-01-05

Publications (2)

Publication Number Publication Date
NO900025D0 NO900025D0 (no) 1990-01-04
NO900025L true NO900025L (no) 1990-07-06

Family

ID=23131076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90900025A NO900025L (no) 1989-01-05 1990-01-04 Pyrrolylfenyl-substituerte hydroksamsyrederivater.

Country Status (12)

Country Link
EP (1) EP0378991A1 (fr)
JP (1) JPH02270861A (fr)
KR (1) KR900011724A (fr)
AU (1) AU4765090A (fr)
CA (1) CA2007085A1 (fr)
DD (1) DD291551A5 (fr)
FI (1) FI900024A (fr)
HU (1) HUT53608A (fr)
IL (1) IL92915A0 (fr)
NO (1) NO900025L (fr)
PT (1) PT92762A (fr)
ZA (1) ZA9050B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5140047A (en) * 1991-05-03 1992-08-18 Smithkline Beecham Corporation Lipoxygenase inhibitors
PL314605A1 (en) * 1993-11-26 1996-09-16 Pfizer Isoxazolin compounds as anti-inflammatory agents
JPH09505081A (ja) * 1994-03-09 1997-05-20 ファイザー・インコーポレーテッド ５−リポキシゲナーゼ阻害物質としてのイソキサゾリン化合物
US6172057B1 (en) 1997-02-27 2001-01-09 American Cyanamid Company N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
DE69823019T2 (de) * 1997-02-27 2005-03-31 Wyeth Holdings Corp. N-hydroxy-2-(alkyl, aryl oder heteroaryl sulfanyl, sulfinyl oder sulfonyl)-3-substituierte alkyl-, aryl- oder heteroarylamide als matrixmetalloproteinaseinhibitoren
EP1284260A4 (fr) * 2000-05-22 2004-03-31 Takeda Chemical Industries Ltd Inhibiteurs de tyrosine phosphatase
CA2423733A1 (fr) * 2000-08-31 2003-02-14 Terukage Hirata Nouveaux derives d'acide propenohydroxamique
US20050159470A1 (en) * 2003-12-19 2005-07-21 Syrrx, Inc. Histone deacetylase inhibitors
KR101368988B1 (ko) 2005-09-16 2014-02-28 다케다 야쿠힌 고교 가부시키가이샤 디펩티딜 펩티다제 억제제
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0082109A3 (fr) * 1981-10-28 1985-04-17 Ciba-Geigy Ag Acides 2-hydroxyphénylacétiques substitués et leurs dérivés
FR2551063A1 (fr) * 1983-08-22 1985-03-01 Inst Nat Sante Rech Med Nouveaux dimethyl-2,5 pyrroles, leur procede de preparation et leur application en therapeutique
NO165341C (no) * 1985-03-16 1991-01-30 Wellcome Found Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksamsyrearylderivater.
US4792560A (en) * 1985-04-03 1988-12-20 Rorer Pharmaceutical Corporation Quinoline hydroxamates and their use as modulators of arachidonic acid metabolic pathways
GB8531838D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives

Also Published As

Publication number Publication date
PT92762A (pt) 1990-07-31
CA2007085A1 (fr) 1990-07-05
EP0378991A1 (fr) 1990-07-25
IL92915A0 (en) 1990-09-17
HUT53608A (en) 1990-11-28
KR900011724A (ko) 1990-08-02
ZA9050B (en) 1990-08-29
FI900024A0 (fi) 1990-01-03
JPH02270861A (ja) 1990-11-05
DD291551A5 (de) 1991-07-04
AU4765090A (en) 1990-07-12
HU900040D0 (en) 1990-03-28
FI900024A (fi) 1990-07-06
NO900025D0 (no) 1990-01-04

Similar Documents

Publication Publication Date Title
DE69014865D1 (de) Peroxycarbonsäure.
DE3874257D1 (de) Hydroxystyren-derivate.
DE69008682D1 (de) Guanidinobenzolderivate.
DE3872937D1 (de) Benzoylaminophenoxybuttersaeure-derivate.
ATE124407T1 (de) Chromanderivate.
NO900025D0 (no) Pyrrolylfenyl-substituerte hydroksamsyrederivater.
DE3786834D1 (de) 5-fluoro-uracil-derivate.
ATE116985T1 (de) Chromanderivate.
DE69017657D1 (de) Pyridinderivate.
NO884361L (no) Katechol-karboksylsyrederivater.
DK10190A (da) 1,1-dioxo-cephem-4-carbothiolsyrederivater
NO892728D0 (no) Aminoalkyl-aminokarbonyl-aminodiolaminosyre derivater somanti-hypertensive midler.
DE3851615D1 (de) Hydroxamsäure-Derivate.
DE59000510D1 (de) N-phenyltetrahydroindazolderivate.
DE69005904D1 (de) Phenylpyrimidonderivate.
DE69019217D1 (de) Perylenquinon (UCN-1028D)-Derivate.
DE58903320D1 (de) Alpha-fluorcarbonsaeurecyclohexylester.
DE69018816D1 (de) Aminosäurederivate.
DE59003499D1 (de) 3-Cyano-4-phenyl-pyrrol-Derivate.
DE69023097D1 (de) Mevalonsäure-Derivate.
DE59002430D1 (de) Cyclopropanoylaminosäureamid-Derivate.
DE69015726D1 (de) Piperidylthiocarbapenem-Derivate.
NO880088D0 (no) 2,1-benzotiazepin-2,2-dioksyd-5-karboksylsyrederivater.
DE69004991D1 (de) Diphenyldiacetylenderivate.
DE69001450D1 (de) Dihydroxynaphthalin-derivate.